The Children’s Hospital of Philadelphia Foundation is about to see a more than $450 million windfall from its ownership stake in a spinout drug company that is being purchased by Roche in a deal worth nearly $5 billion.
The Children’s Hospital of Philadelphia Foundation is about to see a more than $450 million windfall from its ownership stake in a spinout drug company that is being purchased by Roche in a deal worth nearly $5 billion.